Academic Journal
Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis
Title: | Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis |
---|---|
Authors: | Christine M. Bestvina, MD, Jennifer G. Whisenant, PhD, Valter Torri, MD, Alessio Cortellini, MD, Heather Wakelee, MD, Solange Peters, MD, PhD, Elisa Roca, MD, PhD, Alessandro De Toma, MD, Fred R. Hirsch, MD, Hirva Mamdani, MD, Balazs Halmos, MD, Oscar Arrieta, MD, Anne-Cecile Metivier, MD, Mary J. Fidler, MD, Jacobo Rogado, MD, Carolyn J. Presley, MD, MHS, Celine Mascaux, MD, Carlo Genova, MD, PhD, Juan Bautista Blaquier, MD, Alfredo Addeo, MD, Giovanna Finocchiaro, MD, Hina Khan, MD, Julien Mazieres, MD, PhD, Floriana Morgillo, MD, PhD, Jair Bar, MD, Avinash Aujayeb, MBBS, Giannis Mountzios, MD, PhD, Vieri Scotti, MD, Federica Grosso, MD, Erica Geraedts, MD, Ardak N. Zhumagaliyeva, MD, PhD, Leora Horn, MD, Marina Chiara Garassino, MD, Javier Baena, MD |
Source: | JTO Clinical and Research Reports, Vol 3, Iss 8, Pp 100335- (2022) |
Publisher Information: | Elsevier, 2022. |
Publication Year: | 2022 |
Collection: | LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
Subject Terms: | COVID-19, Cancer, Thoracic, NSCLC, TERAVOLT, Registry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
More Details: | Introduction: The Thoracic Centers International coronavirus disease 2019 (COVID-19) Collaboration (TERAVOLT) registry found approximately 30% mortality in patients with thoracic malignancies during the initial COVID-19 surges. Data from South Africa suggested a decrease in severity and mortality with the Omicron wave. Our objective was to assess mortality of patients with thoracic malignancies with the Omicron-predominant wave and evaluate efficacy of vaccination. Methods: A prospective, multicenter observational study was conducted. A total of 28 institutions contributed data from January 14, 2022, to February 4, 2022. Inclusion criteria were any thoracic cancer and a COVID-19 diagnosis on or after November 1, 2021. End points included mortality, hospitalization, symptomatic COVID-19 infection, asymptomatic COVID-19 infection, and delay in cancer therapy. Analysis was done through contingency tables and a multivariable logistic model. Results: We enrolled a total of 346 patients. Median age was 65 years, 52.3% were female, 74.2% were current or former smokers, 86% had NSCLC, 72% had stage IV at time of COVID-19 diagnosis, and 66% were receiving cancer therapy. Variant was unknown for 70%; for those known, Omicron represented 82%. Overall mortality was 3.2%. Using multivariate analysis, COVID-19 vaccination with booster compared with no vaccination had a protective effect on hospitalization or death (OR = 0.30, confidence interval: 0.15–0.57, p = 0.0003), whereas vaccination without booster did not (OR = 0.64, confidence interval: 0.33–1.24, p = 0.1864). Cancer care was delayed in 56.4% of the patients. Conclusions: TERAVOLT found reduced patient mortality with the most recent COVID-19 surge. COVID-19 vaccination with booster improved outcomes of hospitalization or death. Delays in cancer therapy remain an issue, which has the potential to worsen cancer-related mortality. |
Document Type: | article |
File Description: | electronic resource |
Language: | English |
ISSN: | 2666-3643 |
Relation: | http://www.sciencedirect.com/science/article/pii/S2666364322000595; https://doaj.org/toc/2666-3643 |
DOI: | 10.1016/j.jtocrr.2022.100335 |
Access URL: | https://doaj.org/article/40def45b1dee4cd69aa88c393bc82c35 |
Accession Number: | edsdoj.40def45b1dee4cd69aa88c393bc82c35 |
Database: | Directory of Open Access Journals |
FullText | Links: – Type: other Url: https://resolver.ebsco.com:443/public/rma-ftfapi/ejs/direct?AccessToken=4480B615B2AC3D19F36D&Show=Object Text: Availability: 0 CustomLinks: – Url: https://doaj.org/article/40def45b1dee4cd69aa88c393bc82c35 Name: EDS - DOAJ (s8985755) Category: fullText Text: View record from Directory of Open Access Journals MouseOverText: View record from Directory of Open Access Journals – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=26663643&ISBN=&volume=3&issue=8&date=20220801&spage=&pages=&title=JTO Clinical and Research Reports&atitle=Coronavirus%20Disease%202019%20Outcomes%2C%20Patient%20Vaccination%20Status%2C%20and%20Cancer-Related%20Delays%20During%20the%20Omicron%20Wave%3A%20A%20Brief%20Report%20From%20the%20TERAVOLT%20Analysis&aulast=Christine%20M.%20Bestvina%2C%20MD&id=DOI:10.1016/j.jtocrr.2022.100335 Name: Full Text Finder (for New FTF UI) (s8985755) Category: fullText Text: Find It @ SCU Libraries MouseOverText: Find It @ SCU Libraries |
---|---|
Header | DbId: edsdoj DbLabel: Directory of Open Access Journals An: edsdoj.40def45b1dee4cd69aa88c393bc82c35 RelevancyScore: 942 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 942.416687011719 |
IllustrationInfo | |
Items | – Name: Title Label: Title Group: Ti Data: Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Christine+M%2E+Bestvina%2C+MD%22">Christine M. Bestvina, MD</searchLink><br /><searchLink fieldCode="AR" term="%22Jennifer+G%2E+Whisenant%2C+PhD%22">Jennifer G. Whisenant, PhD</searchLink><br /><searchLink fieldCode="AR" term="%22Valter+Torri%2C+MD%22">Valter Torri, MD</searchLink><br /><searchLink fieldCode="AR" term="%22Alessio+Cortellini%2C+MD%22">Alessio Cortellini, MD</searchLink><br /><searchLink fieldCode="AR" term="%22Heather+Wakelee%2C+MD%22">Heather Wakelee, MD</searchLink><br /><searchLink fieldCode="AR" term="%22Solange+Peters%2C+MD%2C+PhD%22">Solange Peters, MD, PhD</searchLink><br /><searchLink fieldCode="AR" term="%22Elisa+Roca%2C+MD%2C+PhD%22">Elisa Roca, MD, PhD</searchLink><br /><searchLink fieldCode="AR" term="%22Alessandro+De+Toma%2C+MD%22">Alessandro De Toma, MD</searchLink><br /><searchLink fieldCode="AR" term="%22Fred+R%2E+Hirsch%2C+MD%22">Fred R. Hirsch, MD</searchLink><br /><searchLink fieldCode="AR" term="%22Hirva+Mamdani%2C+MD%22">Hirva Mamdani, MD</searchLink><br /><searchLink fieldCode="AR" term="%22Balazs+Halmos%2C+MD%22">Balazs Halmos, MD</searchLink><br /><searchLink fieldCode="AR" term="%22Oscar+Arrieta%2C+MD%22">Oscar Arrieta, MD</searchLink><br /><searchLink fieldCode="AR" term="%22Anne-Cecile+Metivier%2C+MD%22">Anne-Cecile Metivier, MD</searchLink><br /><searchLink fieldCode="AR" term="%22Mary+J%2E+Fidler%2C+MD%22">Mary J. Fidler, MD</searchLink><br /><searchLink fieldCode="AR" term="%22Jacobo+Rogado%2C+MD%22">Jacobo Rogado, MD</searchLink><br /><searchLink fieldCode="AR" term="%22Carolyn+J%2E+Presley%2C+MD%2C+MHS%22">Carolyn J. Presley, MD, MHS</searchLink><br /><searchLink fieldCode="AR" term="%22Celine+Mascaux%2C+MD%22">Celine Mascaux, MD</searchLink><br /><searchLink fieldCode="AR" term="%22Carlo+Genova%2C+MD%2C+PhD%22">Carlo Genova, MD, PhD</searchLink><br /><searchLink fieldCode="AR" term="%22Juan+Bautista+Blaquier%2C+MD%22">Juan Bautista Blaquier, MD</searchLink><br /><searchLink fieldCode="AR" term="%22Alfredo+Addeo%2C+MD%22">Alfredo Addeo, MD</searchLink><br /><searchLink fieldCode="AR" term="%22Giovanna+Finocchiaro%2C+MD%22">Giovanna Finocchiaro, MD</searchLink><br /><searchLink fieldCode="AR" term="%22Hina+Khan%2C+MD%22">Hina Khan, MD</searchLink><br /><searchLink fieldCode="AR" term="%22Julien+Mazieres%2C+MD%2C+PhD%22">Julien Mazieres, MD, PhD</searchLink><br /><searchLink fieldCode="AR" term="%22Floriana+Morgillo%2C+MD%2C+PhD%22">Floriana Morgillo, MD, PhD</searchLink><br /><searchLink fieldCode="AR" term="%22Jair+Bar%2C+MD%22">Jair Bar, MD</searchLink><br /><searchLink fieldCode="AR" term="%22Avinash+Aujayeb%2C+MBBS%22">Avinash Aujayeb, MBBS</searchLink><br /><searchLink fieldCode="AR" term="%22Giannis+Mountzios%2C+MD%2C+PhD%22">Giannis Mountzios, MD, PhD</searchLink><br /><searchLink fieldCode="AR" term="%22Vieri+Scotti%2C+MD%22">Vieri Scotti, MD</searchLink><br /><searchLink fieldCode="AR" term="%22Federica+Grosso%2C+MD%22">Federica Grosso, MD</searchLink><br /><searchLink fieldCode="AR" term="%22Erica+Geraedts%2C+MD%22">Erica Geraedts, MD</searchLink><br /><searchLink fieldCode="AR" term="%22Ardak+N%2E+Zhumagaliyeva%2C+MD%2C+PhD%22">Ardak N. Zhumagaliyeva, MD, PhD</searchLink><br /><searchLink fieldCode="AR" term="%22Leora+Horn%2C+MD%22">Leora Horn, MD</searchLink><br /><searchLink fieldCode="AR" term="%22Marina+Chiara+Garassino%2C+MD%22">Marina Chiara Garassino, MD</searchLink><br /><searchLink fieldCode="AR" term="%22Javier+Baena%2C+MD%22">Javier Baena, MD</searchLink> – Name: TitleSource Label: Source Group: Src Data: JTO Clinical and Research Reports, Vol 3, Iss 8, Pp 100335- (2022) – Name: Publisher Label: Publisher Information Group: PubInfo Data: Elsevier, 2022. – Name: DatePubCY Label: Publication Year Group: Date Data: 2022 – Name: Subset Label: Collection Group: HoldingsInfo Data: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22COVID-19%22">COVID-19</searchLink><br /><searchLink fieldCode="DE" term="%22Cancer%22">Cancer</searchLink><br /><searchLink fieldCode="DE" term="%22Thoracic%22">Thoracic</searchLink><br /><searchLink fieldCode="DE" term="%22NSCLC%22">NSCLC</searchLink><br /><searchLink fieldCode="DE" term="%22TERAVOLT%22">TERAVOLT</searchLink><br /><searchLink fieldCode="DE" term="%22Registry%22">Registry</searchLink><br /><searchLink fieldCode="DE" term="%22Neoplasms%2E+Tumors%2E+Oncology%2E+Including+cancer+and+carcinogens%22">Neoplasms. Tumors. Oncology. Including cancer and carcinogens</searchLink><br /><searchLink fieldCode="DE" term="%22RC254-282%22">RC254-282</searchLink> – Name: Abstract Label: Description Group: Ab Data: Introduction: The Thoracic Centers International coronavirus disease 2019 (COVID-19) Collaboration (TERAVOLT) registry found approximately 30% mortality in patients with thoracic malignancies during the initial COVID-19 surges. Data from South Africa suggested a decrease in severity and mortality with the Omicron wave. Our objective was to assess mortality of patients with thoracic malignancies with the Omicron-predominant wave and evaluate efficacy of vaccination. Methods: A prospective, multicenter observational study was conducted. A total of 28 institutions contributed data from January 14, 2022, to February 4, 2022. Inclusion criteria were any thoracic cancer and a COVID-19 diagnosis on or after November 1, 2021. End points included mortality, hospitalization, symptomatic COVID-19 infection, asymptomatic COVID-19 infection, and delay in cancer therapy. Analysis was done through contingency tables and a multivariable logistic model. Results: We enrolled a total of 346 patients. Median age was 65 years, 52.3% were female, 74.2% were current or former smokers, 86% had NSCLC, 72% had stage IV at time of COVID-19 diagnosis, and 66% were receiving cancer therapy. Variant was unknown for 70%; for those known, Omicron represented 82%. Overall mortality was 3.2%. Using multivariate analysis, COVID-19 vaccination with booster compared with no vaccination had a protective effect on hospitalization or death (OR = 0.30, confidence interval: 0.15–0.57, p = 0.0003), whereas vaccination without booster did not (OR = 0.64, confidence interval: 0.33–1.24, p = 0.1864). Cancer care was delayed in 56.4% of the patients. Conclusions: TERAVOLT found reduced patient mortality with the most recent COVID-19 surge. COVID-19 vaccination with booster improved outcomes of hospitalization or death. Delays in cancer therapy remain an issue, which has the potential to worsen cancer-related mortality. – Name: TypeDocument Label: Document Type Group: TypDoc Data: article – Name: Format Label: File Description Group: SrcInfo Data: electronic resource – Name: Language Label: Language Group: Lang Data: English – Name: ISSN Label: ISSN Group: ISSN Data: 2666-3643 – Name: NoteTitleSource Label: Relation Group: SrcInfo Data: http://www.sciencedirect.com/science/article/pii/S2666364322000595; https://doaj.org/toc/2666-3643 – Name: DOI Label: DOI Group: ID Data: 10.1016/j.jtocrr.2022.100335 – Name: URL Label: Access URL Group: URL Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/40def45b1dee4cd69aa88c393bc82c35" linkWindow="_blank">https://doaj.org/article/40def45b1dee4cd69aa88c393bc82c35</link> – Name: AN Label: Accession Number Group: ID Data: edsdoj.40def45b1dee4cd69aa88c393bc82c35 |
PLink | https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.40def45b1dee4cd69aa88c393bc82c35 |
RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jtocrr.2022.100335 Languages: – Text: English Subjects: – SubjectFull: COVID-19 Type: general – SubjectFull: Cancer Type: general – SubjectFull: Thoracic Type: general – SubjectFull: NSCLC Type: general – SubjectFull: TERAVOLT Type: general – SubjectFull: Registry Type: general – SubjectFull: Neoplasms. Tumors. Oncology. Including cancer and carcinogens Type: general – SubjectFull: RC254-282 Type: general Titles: – TitleFull: Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Christine M. Bestvina, MD – PersonEntity: Name: NameFull: Jennifer G. Whisenant, PhD – PersonEntity: Name: NameFull: Valter Torri, MD – PersonEntity: Name: NameFull: Alessio Cortellini, MD – PersonEntity: Name: NameFull: Heather Wakelee, MD – PersonEntity: Name: NameFull: Solange Peters, MD, PhD – PersonEntity: Name: NameFull: Elisa Roca, MD, PhD – PersonEntity: Name: NameFull: Alessandro De Toma, MD – PersonEntity: Name: NameFull: Fred R. Hirsch, MD – PersonEntity: Name: NameFull: Hirva Mamdani, MD – PersonEntity: Name: NameFull: Balazs Halmos, MD – PersonEntity: Name: NameFull: Oscar Arrieta, MD – PersonEntity: Name: NameFull: Anne-Cecile Metivier, MD – PersonEntity: Name: NameFull: Mary J. Fidler, MD – PersonEntity: Name: NameFull: Jacobo Rogado, MD – PersonEntity: Name: NameFull: Carolyn J. Presley, MD, MHS – PersonEntity: Name: NameFull: Celine Mascaux, MD – PersonEntity: Name: NameFull: Carlo Genova, MD, PhD – PersonEntity: Name: NameFull: Juan Bautista Blaquier, MD – PersonEntity: Name: NameFull: Alfredo Addeo, MD – PersonEntity: Name: NameFull: Giovanna Finocchiaro, MD – PersonEntity: Name: NameFull: Hina Khan, MD – PersonEntity: Name: NameFull: Julien Mazieres, MD, PhD – PersonEntity: Name: NameFull: Floriana Morgillo, MD, PhD – PersonEntity: Name: NameFull: Jair Bar, MD – PersonEntity: Name: NameFull: Avinash Aujayeb, MBBS – PersonEntity: Name: NameFull: Giannis Mountzios, MD, PhD – PersonEntity: Name: NameFull: Vieri Scotti, MD – PersonEntity: Name: NameFull: Federica Grosso, MD – PersonEntity: Name: NameFull: Erica Geraedts, MD – PersonEntity: Name: NameFull: Ardak N. Zhumagaliyeva, MD, PhD – PersonEntity: Name: NameFull: Leora Horn, MD – PersonEntity: Name: NameFull: Marina Chiara Garassino, MD – PersonEntity: Name: NameFull: Javier Baena, MD IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 26663643 Numbering: – Type: volume Value: 3 – Type: issue Value: 8 Titles: – TitleFull: JTO Clinical and Research Reports Type: main |
ResultId | 1 |